Clodronate--a new perspective in the treatment of neoplastic bone disease. Proceedings of a meeting. Helsinki. - Suppr | 超能文献

Clodronate--a new perspective in the treatment of neoplastic bone disease. Proceedings of a meeting. Helsinki.

出版信息

Bone. 1987;8 Suppl 1:S1-86.

Abstract

摘要

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

文档翻译

学术文献翻译模型，支持多种主流文档格式。

相似文献

1

Clodronate--a new perspective in the treatment of neoplastic bone disease. Proceedings of a meeting. Helsinki.

Bone. 1987;8 Suppl 1:S1-86.

2

Treatment of skeletal disease in breast cancer: a controlled clodronate trial.乳腺癌骨疾病的治疗：一项氯膦酸盐对照试验

Bone. 1987;8 Suppl 1:S53-6.

3

[Is pamidronate or clodronate better?].

Vnitr Lek. 2002 Apr;48(4):357.

4

Clodronate for osteolytic metastases due to breast cancer.氯膦酸盐用于治疗乳腺癌所致的溶骨性转移。

Biomed Pharmacother. 1988;42(2):111-6.

5

Use of dichloromethylene diphosphonate in metastatic bone disease.二氯亚甲基二膦酸盐在转移性骨病中的应用。

N Engl J Med. 1981 Aug 6;305(6):343-4. doi: 10.1056/NEJM198108063050612.

6

[Diphosphonates in solid malignant tumors].

Ugeskr Laeger. 2005 Jan 24;167(4):379-82.

7

Aredia: the once-monthly infusion for the treatment of bone metastases.阿可达：用于治疗骨转移的每月一次静脉输注药物。

Curr Opin Oncol. 1998 Aug;10 Suppl 1:S1-5.

8

[Diphosphonates in the treatment of bone metastases].[双膦酸盐类药物在骨转移治疗中的应用]

Schweiz Med Wochenschr. 1981 Dec 5;111(49):1878-82.

9

[Clodronate and myeloma].

Duodecim. 1995;111(12):1085-7.

10

Efficacy of clodronate, pamidronate, and zoledronate in reducing morbidity and mortality in cancer patients with bone metastasis: a meta-analysis of randomized clinical trials.氯膦酸盐、帕米膦酸盐和唑来膦酸盐在降低骨转移癌患者发病率和死亡率方面的疗效：一项随机临床试验的荟萃分析。

Clin Ther. 2009 May;31(5):962-79. doi: 10.1016/j.clinthera.2009.05.009.

引用本文的文献

1

A tolerability and pharmacokinetic study of a new injectable formulation of disodium clodronate in healthy female volunteers.氯膦酸二钠新注射剂在健康女性志愿者中的耐受性和药代动力学研究。

Eur J Drug Metab Pharmacokinet. 2004 Apr-Jun;29(2):145-52. doi: 10.1007/BF03190589.

2

Pamidronate in patients with painful bone metastases, who failed initial treatment with hormones and/or chemotherapy.

Support Care Cancer. 1996 Jan;4(1):31-3. doi: 10.1007/BF01769872.

3

Extracellular and intracellular action of clodronate in osteolytic bone diseases? A hypothesis.氯膦酸盐在溶骨性骨疾病中的细胞外和细胞内作用？一种假说。

Calcif Tissue Int. 1993 Jun;52(6):407-10. doi: 10.1007/BF00571326.

4

The effect of 3-amino-1-hydroxypropylidene-1,1-bisphosphonate (ADP) on the resorptive function of osteoclasts of known nuclear number.3-氨基-1-羟基亚丙基-1,1-双膦酸盐（ADP）对已知核数破骨细胞吸收功能的影响。

Calcif Tissue Int. 1994 Jan;54(1):56-61. doi: 10.1007/BF00316291.

5

Anticancer-agent-linked phosphonates with antiosteolytic and antineoplastic properties: a promising perspective in the treatment of bone-related malignancies?具有抗溶骨和抗肿瘤特性的抗癌剂连接膦酸盐：在治疗骨相关恶性肿瘤方面有前景吗？

J Cancer Res Clin Oncol. 1990;116(4):341-50. doi: 10.1007/BF01612916.